Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

P&G sells Aleve, Femstat

Published on .

Procter & Gamble Co. is dumping its Aleve pain reliever and Femstat 3 vaginal treatment brands to focus on "leadership brands, like Crest and Vicks, worldwide and investing in new OTC and Rx brands where recent progress is most encouraging," said P&G Chairman-CEO John Pepper. P&G said it sold its 50% stake in Procter-Syntex Health Products to Roche Holding, owner of the other half of the joint venture, Syntex Laboratories (now Roche Bioscience). Terms of the move, which must be approved by the U.S. government, were not disclosed. P&G will continue providing sales and marketing of the brands for a year.

Most Popular
In this article: